Amelogenin-assisted ex vivo remineralization of human enamel: Effects of supersaturation degree and fluoride concentration.
The formation of organized nanocrystals that resemble enamel is crucial for successful enamel remineralization. Calcium, phosphate and fluoride ions, and amelogenin are important ingredients for the formation of organized hydroxyapatite (HAP) crystals in vitro. However, the effects of these remineralization agents on the enamel crystal morphology have not been thoroughly studied. The objective of this study was to investigate the effects of fluoride ions, supersaturation degree and amelogenin on the crystal morphology and organization of ex vivo remineralized human enamel. Extracted third molars were sliced thin and acid-etched to provide the enamel surface for immersion in different remineralization solutions. The crystal morphology and mineral phase of the remineralized enamel surface were analyzed by field emission-scanning electron microscopy, attenuated total reflection-Fourier transformed infrared and X-ray diffraction. The concentration of fluoride and the supersaturation degree of hydroxyapatite had significant effects on the crystal morphology and crystal organization, which varied from plate-like loose crystals to rod-like densely packed nanocrystal arrays. Densely packed arrays of fluoridated hydroxyapatite nanorods were observed under the following conditions: σ(HAP)=10.2±2.0 with 1.5±0.5 mg l(-1) fluoride and 40±10 μg ml(-1) amelogenin, pH 6.8±0.4. A phase diagram summarizes the conditions that form dense or loose hydroxyapatite nanocrystal structures. This study provides the basis for the development of novel dental materials for caries management.
Department of Comprehensive Dentistry and Biomaterials, School of Dentistry, Louisiana State University Health Science Center, New Orleans, 70119, USA. yfan@lsuhsc.edu
Yuwei
Y
Fan
James R
JR
Nelson
Jason R
JR
Alvarez
Joseph
J
Hagan
Allison
A
Berrier
Xiaoming
X
Xu
D000134:Acid Etching, Dental; D053523:Amelogenin / Q000494:pharmacology*; D000818:Animals; D002118:Calcium / Q000494:pharmacology; D003460:Crystallization; D003743:Dental Enamel / Q000187:drug effects* / Q000648:ultrastructure; D005459:Fluorides / Q000494:pharmacology*; D006244:Hardness / Q000187:drug effects; D006801:Humans; D006863:Hydrogen-Ion Concentration / Q000187:drug effects; D017550:Spectroscopy, Fourier Transform Infrared; D034421:Sus scrofa; D013997:Time Factors; D014089:Tooth Remineralization; D014961:X-Ray Diffraction
D053523:Amelogenin; D005459:Fluorides; D002118:Calcium
J Phys Chem B. 2009 Dec 24;113(51):16393-9
19928979
Caries Res. 2001;35 Suppl 1:45-51
11359058
J Phys Chem B. 2010 Feb 18;114(6):2293-300
20104924
Nature. 2005 Feb 24;433(7028):819
15729330
J Dent Res. 2002 Jan;81(1):69-73
11820371
Caries Res. 2009;43(2):132-6
19321991
Crit Rev Oral Biol Med. 1992;3(1-2):61-82
1730071
J Dent Res. 2008 Apr;87(4):344-8
18362316
J Phys Chem C Nanomater Interfaces. 2008 Mar 22;112(15):5892-5899
19169386
J Struct Biol. 2007 Oct;160(1):57-69
17719243
J Struct Biol. 2009 May;166(2):133-43
19217943
Eur J Oral Sci. 2006 May;114 Suppl 1:289-96; discussion 327-9, 382
16674701
Biomaterials. 2009 Feb;30(4):478-83
18996587
Oper Dent. 2008 Sep-Oct;33(5):550-5
18833861
J Can Dent Assoc. 2008 Feb;74(1):73-9
18298889
J Nanosci Nanotechnol. 2009 Feb;9(2):1361-4
19441525
Biomaterials. 2007 Jul;28(19):3034-42
17382381
Calcif Tissue Int. 1992 Apr;50(4):357-61
1571848
J Dent Res. 1999 Mar;78(3):743-50
10096449
Cells Tissues Organs. 2005;181(3-4):202-18
16612086
J Struct Biol. 2005 Feb;149(2):182-90
15681234
Acta Biomater. 2009 Jul;5(6):2152-60
19286435
Caries Res. 2001;35 Suppl 1:18-21
11359052
J Dent Res. 2006 Sep;85(9):775-93
16931858
Chem Commun (Camb). 2009 Oct 21;(39):5892-4
19787132
J Biomed Mater Res A. 2003 Mar 1;64(3):483-90
12579562
Chem Rev. 2008 Nov;108(11):4628-69
18816145